Nautilus Biotechnology, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol: NAUT on Nasdaq
Industry: Laboratory Analytical Instruments
Location: 2701 Eastlake Ave East, Seattle, WA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+50K	37.9%	$2.81	+$141K
Sells	1	-82K	62.1%	$2.86	-$235K
Net	0	-32K	-24.3%		-$94.1K

Nautilus Biotechnology, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Sujal M. Patel	CEO, President, and Secretary, Director, 10%+ Owner	$48.7M	+$141K	+0.29%	Mar 8, 2024
AH Equity Partners Bio II, L.L.C.	10%+ Owner	$35.8M			Jun 9, 2021
Mary E. Godwin	Senior VP, Operations	$0	-$235K	-100%	Sep 23, 2024
Karen Akinsanya	Director				Jun 14, 2024
Melissa Epperly	Director				Jun 14, 2024
Perceptive Advisors Llc	Director, 10%+ Owner				Jun 14, 2024
Matthew L. Posard	Director				Jun 14, 2024
Farzad Nazem	Director				Jun 14, 2024
Parag Mallick	Chief Scientist, Director, 10%+ Owner				Mar 1, 2024
Matthew B. Murphy	General Counsel				Mar 1, 2024
Matthew McIlwain	Director				Jun 14, 2024
Vijay Satyanand Pande	Director				Jun 14, 2024
Subramanian Sankar	Senior VP, Product Development				Mar 1, 2024
Nicholas A. Nelson	CBO & Senior VP, Bus. Dev.				Mar 1, 2024
Kentaro Suzuki	Chief Marketing Officer				Sep 16, 2024
Anna Mowry	CFO and Treasurer				Mar 1, 2024
Michael Seth Altman	Director				Jun 14, 2024
Gwen E. Weld	Chief People Officer				Mar 1, 2024

Recent Insider Transactions by Companies or Individuals for Nautilus Biotechnology, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.